ArticleScientific reports2026
Semicircular canal dysfunction in profound sudden sensorineural hearing loss and its prognostic value: implications for the proper indication of hyperbaric oxygen therapy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Vestibular involvement in sudden sensorineural hearing loss (SSNHL) is regarded as an indicator of poor prognosis. This study aimed to investigate the prognostic significance of semicircular canal dysfunction in profound SSNHL and evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) accordingly. From October 1, 2020 to August 15, 2025, patients diagnosed with profound SSNHL (≥ 80 dB) and with available video head impulse test results were assessed. A total of 85 patients were included and divided into two groups based on HBOT compliance: the HBOT group (≥ 5 sessions, n = 39) and the non-HBOT group (< 5 sessions, n = 46). Semicircular canal function and treatment outcomes were compared. PSCC dysfunction was independently associated with about 14 dB poorer post-treatment mean hearing thresholds (76.00 ± 3.43 dB vs. 62.26 ± 3.75 dB, p = 0.011). In these patients with PSCC dysfunction, HBOT was associated with improved post-treatment mean hearing thresholds (74.32 ± 2.90 dB vs. 89.22 ± 3.17 dB; p = 0.002), with significant improvements at 0.5, 1, 2, and 4 kHz (all p < 0.05). PSCC dysfunction is associated with poorer hearing recovery in patients with profound SSNHL and may help identify a distinct clinical phenotype that is more likely to benefit from HBOT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.